Skip to main content

ADVERTISEMENT

tolerability

Abstracts
08/23/2024
Systemic therapies for metastatic colorectal cancer (mCRC) have distinct safety and tolerability profiles. Adverse events (AEs) may occur and compromise the course of treatment, increase health care utilization and costs, and worsen patients’...
Systemic therapies for metastatic colorectal cancer (mCRC) have distinct safety and tolerability profiles. Adverse events (AEs) may occur and compromise the course of treatment, increase health care utilization and costs, and worsen patients’...
Systemic therapies for...
08/23/2024
Journal of Clinical Pathways